Skip to content
Screener
CYP

Cypherpunk Technologies

CYPH

Cypherpunk Technologies is a privacy technology company focused on the development and acquisition of privacy-enhancing infrastructure and digital assets.

Market cap
$175.66M+179%
Net income-$877.0K+98.7%
EPS (diluted)$0.56+135%
Trailing twelve months · change vs. prior year

Earnings

Q2 2026 report

August 12, 2026

Next report

Nov 11, 2026 (in 2 months)
Revenue estimate$8.9M
EPS estimate$0.01

Financials

Q2 2026

Income statement

See full
Operating income-$4.7M+72.2%
Net income$39.4M+337%
EPS (diluted)$0.18+145%

Balance sheet

See full
Cash & equivalents$7.6M-57.9%
Total debt$38.0K-2.6%
Total equity$139.3M+2,337%
Total assets$143.0M+613%

Cash flow

See full
Operating cash flow-$2.7M+81.4%

Valuation & ratios

Valuation

See full
Market cap$175.66M+179%
Enterprise value$168.07M

Returns & leverage

See full
Return on equity-1.2%-0.6pp
Debt / equity0.0×
Current ratio79.2×+77.9×

Competitors

Profile

Cypherpunk Technologies is a privacy technology company focused on the development and acquisition of privacy-enhancing infrastructure and digital assets. The company operates a dual-track strategy: managing a digital asset treasury anchored by Zcash (ZEC) and developing novel biomarker-targeted antibody therapies for cancer through its subsidiary, Leap Therapeutics.

Competitive position

A unique hybrid entity combining a digital asset treasury focused on privacy protocols with a clinical-stage biotechnology pipeline.

GeographiesUnited States, Australia
Customer segmentsBlockchain Ecosystems, Healthcare Institutions, Retail and Institutional Investors
Business modelAsset Treasury, R&D, Licensing
SuppliersZcash Network miners, Contract Manufacturing Organizations (CMOs), Open-source protocol contributors, Clinical trial sites
CustomersDigital asset exchanges, Biopharmaceutical companies, Oncology clinics, Institutional digital asset holders
Listed2014
CEODouglas E. Onsi
Websiteleaptx.com
FilingsSEC EDGAR

FAQ

What is Cypherpunk Technologies's market cap?
Cypherpunk Technologies (CYPH) has a market capitalization of $175.7M and trades on NASDAQ.
Who are Cypherpunk Technologies's competitors?
Cypherpunk Technologies's key competitors include MicroStrategy Inc., Merck, Pfizer, and others. These companies compete in similar markets and product categories.
Who does Cypherpunk Technologies partner with?
Cypherpunk Technologies's notable partners include Winklevoss Capital, Zcash Open Development Lab (ZODL), Eli Lilly and Company, and others.
What subsidiaries does Cypherpunk Technologies have?
Cypherpunk Technologies's subsidiaries include Leap Therapeutics, Inc., HealthCare Pharmaceuticals Pty Ltd., Leap Securities Corp., and others.
Where is Cypherpunk Technologies headquartered?
Cypherpunk Technologies is headquartered in United States of America. It has been publicly traded since 2014.